These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20922534)

  • 1. A novel phenylpyridazinone, T-3999, reduces the progression of autoimmune myocarditis to dilated cardiomyopathy.
    Kamal FA; Watanabe K; Ma M; Abe Y; Elbarbary R; Kodama M; Aizawa Y
    Heart Vessels; 2011 Jan; 26(1):81-90. PubMed ID: 20922534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
    Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1338-46. PubMed ID: 20876084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model.
    Hirata Y; Kurobe H; Uematsu E; Yagi S; Soeki T; Yamada H; Fukuda D; Shimabukuro M; Nakayama M; Matsumoto K; Sakai Y; Kitagawa T; Sata M
    Eur J Pharmacol; 2013 Jan; 699(1-3):81-7. PubMed ID: 23219794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
    Palaniyandi SS; Nagai Y; Watanabe K; Ma M; Veeraveedu PT; Prakash P; Kamal FA; Abe Y; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1213-21. PubMed ID: 17895529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Eur J Pharmacol; 2008 Feb; 581(1-2):121-31. PubMed ID: 18154949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin offers cardioprotection against progression of experimental autoimmune myocarditis by suppression of oxidative and endoplasmic reticulum stress via endothelin-1/MAPK signalling.
    Arumugam S; Thandavarayan RA; Arozal W; Sari FR; Giridharan VV; Soetikno V; Palaniyandi SS; Harima M; Suzuki K; Nagata M; Tagaki R; Kodama M; Watanabe K
    Free Radic Res; 2012 Feb; 46(2):154-63. PubMed ID: 22145946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin, a naturally occurring anthraquinone, ameliorates experimental autoimmune myocarditis in rats.
    Song ZC; Wang ZS; Bai JH; Li Z; Hu J
    Tohoku J Exp Med; 2012 Jul; 227(3):225-30. PubMed ID: 22791134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis.
    Watanabe K; Sukumaran V; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Arozal W; Sari FR; Lakshmanan AP; Arumugam S; Soetikno V; Rajavel V; Suzuki K
    Inflamm Allergy Drug Targets; 2011 Jun; 10(3):218-25. PubMed ID: 21495969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy.
    Palaniyandi Selvaraj S; Watanabe K; Ma M; Tachikawa H; Kodama M; Aizawa Y
    Biol Pharm Bull; 2005 Nov; 28(11):2128-32. PubMed ID: 16272703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine suppresses the progression of ventricular remodeling in acute myocarditis: studies in an experimental autoimmune myocarditis (EAM) model.
    Niwano S; Niwano H; Sasaki S; Fukaya H; Yuge M; Imaki R; Machida Y; Izumi T
    Circ J; 2011; 75(3):662-71. PubMed ID: 21187656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis.
    Koyama S; Kodama M; Izumi T; Shibata A
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):701-7. PubMed ID: 8573553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.
    Fairweather D; Frisancho-Kiss S; Yusung SA; Barrett MA; Davis SE; Gatewood SJ; Njoku DB; Rose NR
    Am J Pathol; 2004 Dec; 165(6):1883-94. PubMed ID: 15579433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
    Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Hypertens Res; 2010 Jul; 33(7):695-702. PubMed ID: 20535115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mulberry leaf diet protects against progression of experimental autoimmune myocarditis to dilated cardiomyopathy via modulation of oxidative stress and MAPK-mediated apoptosis.
    Arumugam S; Mito S; Thandavarayan RA; Giridharan VV; Pitchaimani V; Karuppagounder V; Harima M; Nomoto M; Suzuki K; Watanabe K
    Cardiovasc Ther; 2013 Dec; 31(6):352-62. PubMed ID: 23480557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small interfering RNA therapy against carbohydrate sulfotransferase 15 inhibits cardiac remodeling in rats with dilated cardiomyopathy.
    Watanabe K; Arumugam S; Sreedhar R; Thandavarayan RA; Nakamura T; Nakamura M; Harima M; Yoneyama H; Suzuki K
    Cell Signal; 2015 Jul; 27(7):1517-24. PubMed ID: 25778904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropeptide cortistatin attenuates experimental autoimmune myocarditis via inhibition of cardiomyogenic T cell-driven inflammatory responses.
    Delgado-Maroto V; Falo CP; Forte-Lago I; Adan N; Morell M; Maganto-Garcia E; Robledo G; O'Valle F; Lichtman AH; Gonzalez-Rey E; Delgado M
    Br J Pharmacol; 2017 Feb; 174(3):267-280. PubMed ID: 27922195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
    Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
    Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
    Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
    J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy.
    Arumugam S; Thandavarayan RA; Veeraveedu PT; Nakamura T; Arozal W; Sari FR; Giridharan VV; Soetikno V; Palaniyandi SS; Harima M; Suzuki K; Nagata M; Kodama M; Watanabe K
    J Cell Mol Med; 2012 Sep; 16(9):2176-85. PubMed ID: 22268705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin ameliorates experimental autoimmune myocarditis in rats.
    Milenković M; Arsenović-Ranin N; Stojić-Vukanić Z; Bufan B; Vučićević D; Jančić I
    J Pharm Pharm Sci; 2010; 13(3):311-9. PubMed ID: 21092705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.